Similarities and differences between pediatric and adult patients with systemic lupus erythematosus

T Tarr1, B Dérfalvi2, N Győri1

  • 1Department of Clinical Immunology, University of Debrecen, Hungary.

Lupus
|December 18, 2014
PubMed

Insights

Pediatric-onset systemic lupus erythematosus (SLE) presents with more kidney, blood, skin, and mouth issues than adult-onset SLE. Adult-onset SLE more frequently involves neurological symptoms and joint pain, differing in antibody profiles and treatments.

Area of Science:

  • Rheumatology
  • Pediatric Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune condition.
  • While prevalent in women of childbearing age, SLE can also affect children (pediatric-onset SLE).
  • Understanding differences between adult and pediatric SLE is crucial for effective management.

Purpose of the Study:

  • To compare the clinical course of adult-onset SLE versus pediatric-onset SLE.
  • To identify distinct organ manifestations, laboratory findings, and immunoserological characteristics.
  • To inform optimal treatment strategies and prognosis for different age groups.

Main Methods:

  • Retrospective analysis of medical records from 342 adult patients and 79 pediatric patients.
  • Review of organ manifestations, laboratory parameters, and immunoserological data.
  • Statistical evaluation using SPSS software.

Main Results:

  • Pediatric SLE showed higher rates of lupus nephritis, hematological disorders, photosensitivity, butterfly rash, and mucosal ulceration.
  • Adult SLE exhibited more frequent neurological symptoms and polyarthritis.
  • Adult-onset SLE had higher levels of anti-SSA, anti-SSB, and antiphospholipid antibodies; children received more IV immunoglobulin and mycophenolate mofetil.

Conclusions:

  • Pediatric and adult-onset SLE exhibit significant differences in clinical presentation, serology, and treatment.
  • Recognizing these distinctions is vital for tailoring patient care and improving outcomes.
  • Further research into age-specific SLE pathogenesis and management is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
935
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
334